Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in Adult Patients With Acute Lymphoblastic Leukemia/Lymphoma
NCT01649622Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2012
- Primary completion
- Dec 2018
01
Overview
A Phase 2 trial of bendamustine in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LBL), sponsored by University of Texas MD Anderson Cancer Center. Planned start Dec 2012; status: withdrawn.
02
Drugs
bendamustine
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LBL)
Beyond the preview
Go deeper on NCT01649622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649622.